Secrets of Daytrading - How Market Makers work

This is one of many secrets "learned by me over the years in the daytrading school of hard knocks". This secret deals with the level 2 and how market makers move stocks through different levels. It happens on both the upside and the downside. Even though I focus and mainly trade stocks between $1 to $10 per share this happens to every stock - let me explain.
First on the downside because stocks fall faster then they go up. Too bad all stocks are not shortable but you can buy every stock long - go figure.

Lets use ROSG as example - this chart is a 2 day 60 minute chart - it dispalys my point exactly. On the way up 2 days ago it went from 5.75 to 5.80 - once above the 5.80 with volume a stock will climb to towards the 6.00 mark. At 5.90 volume starts kicking in and at 5.93 I do my entry buy and want to buy more after breaks 5.95 which confirms he break for me, then at 5.98 and 5.99- I will bet the house it will go thru 6.00 and when approaches the 5.98 and 5.99 - you can seel the HUGE size on the offer and no fear it always takes that 6.00 out. It goes to 6.01 and touches 6.02 for a sec and then reverses right back under 6.00 to low 5.97 and - it gets quickly sucked up by the smart traders who buy on the way down and sell on the way up. So now I am long at 5.93 and 5.96 and 5.98 even - as long as volume flowing the stock will go back tru 6.00 and creep thru the 6.02 and move past 6.05 - at that point I watch raising my stop to 6.01 - 6.02
The stock at 6.08 and 6.09 I bet the house it goes thru 6.10 (that ..10 cent mark) and flies to 6.13 - ticks down one cent and moves to 6.15, 6.16, 6.17 - back tick to 6.15 -shorters caught buying continues and we see 6.17, 6.18, 6.19 - at 6.19 I bet the house it goes thru 6.20 - After it takes out 6.20 it whipsaws around until it moves to 6.26 then the buyer put in the limits to buy up to 6.30 and it goes againat 6.28 and 6.29 I bet house it takes out the 6.30 - at every even mark 6.10, 6.20, 6.30 there is huge size on the offer with a whole row of them there and they get taken every time.
You see that from the green left side of the ROSG chart.
Now look at the other side - yesterday - the downside same thing - started at 6.60 then dropeed to 6.50 (huge short there) and went to 6.44 - when it at 6.43 and 6.42 - I bet half house and when at 6.41 I bet the whole house it will take it the 6.40's and go right to 6.37 - pop back - retest 6.37 and hello below 6.35. At 6.32 and 6.31 - Bet house it takes out 6.30 and you can see them all there lined up with huge size on the bid (same the other way)
It will continue to do this at every ten cent interval. At 6.14 I love the short as it goes fast under 6.10 - 6.09 6.08 entry shorts and 6.03 and 6.02 - I AM ALL IN!!! ake out 6.00 and go right ot 5.967 - .97 - tick back to 6.00 and retest and take out 5.97 - headed in the 5.80' and then 5.70's and 5.60's and 5.50's - see the chart
This happens with AAPL ex - going up - its up 1 point so far to 595 at 597 I entry and 599 I bet house it takes out 600 and goes right to 603 - back s back to 599 -600 and flies back up to take out the 603 and go to 608 and at 609 I bet house it takes out 610 its the same thing on boith sides just bigger intervals.
When I trade the market (DIA stock symbol) or emini S&P's as the dow jones moves higher from up 30 to up 40 to up 45 to up 46 I entry buy and up 48 and 49 I bet house market continues to up 50+ to 53 - backs off real quick and retests the 53 and goes up 60 then 70 then 80 then 90 at 96 I entry buy and bet house at 98 and 99 market going thur the magic 100 points for the day - Its the same on the downside.
That is my secret for the day hope you all learned something and use it to make yourself huge profits and limit your losses (if you buy at 8.83 and it goes to 8.82 then 8.81 - I guarnatee you got terrible print and going to test you know as it goes under 8.80 - your trapped now)
Averaging down you only do to trade out of a stock - it rarely goes back to where you biugh tit - Averaging up you know your a hero and have a winner - just don tbe greedy and sell on those spikes) Just need a few hits a day - no homers - Good night!

GALE - Galena Biopharma - is now an overnight hold long at 1.77

SVNT - long at 1.36 to 1.40 - see charts

H

uge size on offer means ususally going higher as when it going down and huge on bid flies thru it - get ready for 1.50 see charts

Knight Capital Group Inc. Stock Downgraded (KCG)at TheStreet(Wed 5:00AM EDT)

This could be the spark.

Knight Capital Group Inc. Stock Downgraded (KCG)at TheStreet(Wed 5:00AM EDT)

NEW YORK (TheStreet) -- Knight Capital Group (NYSE:KCG) has been downgraded by TheStreet Ratings from hold to sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, poor profit margins, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.

The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Capital Markets industry. The net income has significantly decreased by 81.3% when compared to the same quarter one year ago, falling from $17.57 million to $3.29 million.

The gross profit margin for KNIGHT CAPITAL GROUP INC is currently extremely low, coming in at 8.20%. It has decreased from the same quarter the previous year. Along with this, the net profit margin of 1.20% significantly trails the industry average. Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 77.68%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 78.94% compared to the year-earlier quarter. Turning toward the future, the fact that the stock has come down in price over the past year should not necessarily be interpreted as a negative; it could be one of the factors that may help make the stock attractive down the road. Right now, however, we believe that it is too soon to buy.

KNIGHT CAPITAL GROUP INC has exprienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, KNIGHT CAPITAL GROUP INC increased its bottom line by earning $1.24 versus $0.98 in the prior year. For the next year, the market is expecting a contraction of 161.3% in earnings (-$0.76 versus $1.24).

The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. When compared to other companies in the Capital Markets industry and the overall market, KNIGHT CAPITAL GROUP INC's return on equity is below that of both the industry average and the S&P 500.

Knight Capital Group, Inc., a financial services company, provides access to the capital markets across multiple asset classes to buy-and sell-side firms and corporations, as well as offers capital markets services to corporate issuers and private companies primarily in the United States. The company has a P/E ratio of 2.5, equal to the average financial services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Knight Capital Group has a market cap of $273.9 million and is part of the financial sector and financial services industry. Shares are down 76.5% year to date as of the close of trading on Tuesday.

KCG - Knight Capital Group - Up Up and Away

$KCG today went to 2.70 - 2.71 - I was thinking wow not much volume and the stock is so cheap. I told some peeps to buy some. They are so many eyeballs (big institutional) watching this stock. Knight Capital Group has traded like a falling daytrade. I'll explain - when long a stock and it's flying high things are great, then all sudden it reverses and starts to go down. Like RGEN yesterday traded up to 6.37 and reversed - This happens everytime - it goes down and when approaches the 6.22 mark will break down further to the teens then cracks 6.10 - and all the shorters stack up and buy at 6.09, 6.08, 6.07 - (smart money buys on way down, and sells on way up) then it firms up and goes back to 6.12. Two minutes later retests the 6.07 and breaks toward 6.05, 6.04 - once it hits there the fast selling comes in and you can see the huge size on the bid at 6.00 - at this mark it gets very fast and takes out all the 6.00 and then does the same thing - all the shorters cover 5.99, 5.98 5.97 - it touches back to 6.00 then gets walloped to 5.90 and takes that out then to 5.80 and takes that out then to 5.75 range where it starts to consolidate from overselling. Over next day or so it drops further to 5.70 to 5.60 to 5.50 5.40 - this is where I bought today at 5.43 and sold later in the day at 5.60 (made .17 cent daytrade profit) - Now it will whipsaw around but my point is at these even numbered marks stocks always react this way and its no different for KCG. The stock went from 4 to 3.50 to 3.00 - the smart money covered 2.99,2.98.297 - it bounced back over 3.00 and then dropped to retest the 2.97 and went to 2.90 then 2.80 then 2.70 - this was the bottom 2.70 as today it ran from 2.73 to 2.84 on huge volume very fast. The day this trades 100MM shares and it will again it will go up 1.00 in one day. That puts it at 4.00 and the next day 1.00 more ot $5.00 - may even go three days to 5.50 $6.00 range, IMO of course.

My previous post

Here is what going on with KCG IMO - Stock plummetts - everyone stuck with huge margin calls - they can delay and strectch it a month and have to either sell it or come up with $$$$$. Usually its sold at lowest levels - The big players do this on purpose to hold it down and collect all this cheap stock then in a week or two after the month is and your stock is gone it runs right back up close to where it plummetted. Your like WTF - I just lost all my money and a month later after I sold it's right back. A prime example is ES - look at the chart on this and the chart on KCG and the timelines.

KCG BUY TARGET = 2.75 to 2.85 - stop loss 2.40

KCG SELL TARGET = $5.50 to $6.00

KCG - EOD trade - huge buyer - somebody knows something - this was last of the suck outs at 2.73 - 3.00 tommorrow??

$SCLN - major mojo analysis - check out chart - trade breakouts for big profits

$SCLN - major mojo analysis - check out chart - trade breakouts for big profits

SCLN - SiClone Pharmaceuticals - 5 minute chart looks good to go to 5.20++

Monday Morning 8/27 - Trade Outlook - ARNA - Arena Pharma

Stock is up to 8.69 by 8.70 - if trades thru the 8.75 - will be close enough on it's way back thru 9.00 - we should see it pop thru that and move to 9.35+ - this as you all know it well can happen TODAY - possible .60 cent move to make. Many other bio's are hot premarket - ROSG - Rosetta Geonomics and SRPT - Serpta Theraputics - up .70 cents to 11.50

KCG - Article - Trading stocks that trigger major breakouts can lead to massive profits

5 Stocks Poised for Breakouts - views

Stock Quotes in this Article: CGR, HTZ, KCG, TGB, UBNT

By Roberto Pedone

Senior Contributor

08/24/12 - 12:31 PM EDT

WINDERMERE, Fla. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high, or takes out a prior overhead resistance point, then it’s free to find new buyers and momentum players that can ultimately push the stock significantly higher.

One recent example of a successful breakout trade that I flagged was biotechnology and drugs player Rosetta Genomics (ROSG). In “5 Stocks Under $10 Set to Soar” on Aug. 9, I mentioned that ROSG was nearing some major previous support levels at $4 to $3.75 a share, and that the stock was extremely oversold. I said that ROSG was poised for a monster bounce if the stock held those levels, and if big upside volume started to flow into the name.

Now, technically, I didn’t mention any breakout levels in that article, since none had developed at that time with the stock trending near those previous support levels. That said, I did tweet out continued commentary on ROSG as the trade setup, and then the stock went on to trigger a major breakout.

Shares of ROSG exploded higher on Wednesday by around 40% as it triggered a major breakout trade above a number of key overhead resistance levels at $4.85 to $5.23 a share with massive volume. As I write this piece, ROSG is up another 7% today as the stock continues to advance above its 200-day moving average of $6.10 a share. If this uptrend continues for ROSG, then this stock will setup to trigger another breakout trade above its 50-day moving average of $8.65 a share.

Knight Capital Group

A stock in the investment services complex that’s trending within range of triggering a near-term breakout trade is Knight Capital Group (KCG), a global financial services firm that provides access to the capital markets across multiple asset classes to a network of clients, including buy- and sell-side firms and corporations. This stock has been hammered by the bears so far in 2012, with shares down by over 75%.

If you look at the chart for Knight Capital Group, you’ll notice that this stock plunged and gapped down huge earlier this month from around $10.50 to its recent low of $2.27 a share with massive volume. That crash has pushed KCG into extremely oversold territory, since its current relative strength index (RSI) reading is now 20.88. Following that crash, shares of KCG have now started to uptrend a bit with the stock making lower highs from $2.27 to $2.75 a share. If that pattern can hold, then KCG has a chance of triggering a near-term breakout trade.

Taseko Mines

One stock that looks poised to trigger a major breakout soon is Taseko Mines (TGB), which is focused on the production of copper and molybdenum from the Gibraltar mine and on permitting the New Prosperity gold and copper project. This stock has been beaten down by the sellers during the last six months, with shares off by over 30%.

If you take a look at the chart for Taseko Mines, you’ll notice that this stock has formed a major bottoming chart pattern over the last three months, with shares finding buying interest whenever its traded down to $2.45 to $2.46 a share. Following that double bottom chart pattern, shares of TBG have started to uptrend back above its 50-day moving average of $2.65 a share with decent volume. That move has now pushed TGB within range of triggering a near-term breakout trade.

Claude Resources

Another stock that looks ready to trigger a powerful breakout trade is Claude Resources (CGR), which is engaged in the acquisition, exploration, and development of precious metal properties and the production and marketing of minerals. Claude's mineral properties are located in northern Saskatchewan and northwestern Ontario. This stock has been crushed by the sellers so far this year, with shares off by over 45%.

If you take a look at the chart for Claude Resources, you’ll see that this stock has been trading range bound for the past four months, between 56 cents to 57 cents on the downside and 76 cents on the upside. That chart pattern has so far marked a triple bottom for CGR off of 56 cents per share. Now CGR is starting to recapture its 50-day moving average of 64 cents per share with decent volume. That move is quickly pushing CGR within range of triggering a major breakout trade.

Market players should now look for long-biased traders in CGR if this stock can manage to trigger a breakout trade above some near-term overhead resistance levels at 73 cents to 76 cents per share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 296,069 shares. If that breakout triggers soon, then CGR could explode to the upside and possibly hit its next major overhead resistance levels at 90 cents to $1.20 a share.

One can look to buy CGR off any weakness and anticipate that breakout, and simply use a stop that sits near its 50-day moving average of 64 cents per share. Or you could just buy off strength once CGR clears 73 cents to 76 cents per share with high volume, and then simply use a stop somewhere around 67 cents per share. I would add to either position once CGR closes above 76 cents per share with heavy volume.

$BCRX - coming out long base looks good long 4.03

Rosetta Genomics, Ltd. (ROSG) - maded .80 cent profit today 8/23

LULU - great trade 61.75 to 62.75

NIce one for a 1 point run

EXEL - looks nice to come out of long base - many stocks doing this now - look at ZNGA and next is KCG

EXEL - looks nice to come out of long base - many stocks doing this now - look at ZNGA and next is KCG

ZNGA perefect example of the manipulation play

THE BIG BOYS CLEARED OUT EVERYONES STOCK CHEAP CHEAP - ALL MARGIN CALLS ARE COVERED NOW - STOCK RUNS BACK TO $4.00

BAC - Bank of America Great Trade 8.38 to 8.16

MERU - MERU Networks can be like REED

Both in hot sectors with small floats - good numbers - institutions jumping in - similar to CANSLIM - if you dont know what that is look it up - William O'neil and CANSLIM http://protradermike.blogspot.com/2012/08/reed-now-490-take-look-how-i-saw-it.html

Hot Stocks for Monday 8/20 - TPLM - Triangle Petroleum & KOG Kodiak Oil & Gas

Triangle Petroleum TPLM - This one buy here 6.75 and target is 8.35 to 8.75

Kodiak Oil & gas - KOG This one buy here 9.30 and target is 11.00 to 11.50

Knight Capital Group - KCG - major BUY and major manipulation

Here is what going on with KCG IMO - Stock plummetts - everyone stuck with huge margin calls - they can delay and strectch it a month and have to either sell it or come up with $$$$$. Usually its sold at lowest levels - The big players do this on purpose to hold it down and collect all this cheap stock then in a week or two after the month is and your stock is gone it runs right back up close to where it plummetted. Your like WTF - I just lost all my money and a month later after I sold it's right back. A prime example is ES - look at the chart on this and the chart on KCG and the timelines.
KCG BUY TARGET = 2.75 to 2.85 - stop loss 2.40
KCG SELL TARGET = $5.50 to $6.00

PPHM - great trade 2.83 to 2.98

Is PDL BioPharma the Perfect Penny Stock?

Is PDL BioPharma the Perfect Penny Stock?

By Rich Duprey

August 13, 2012

Low-priced stocks are often low-priced for a reason: They have significant problems to overcome. Yet for those that have fixed their problems, they may be ready to take off to the next level.

At Motley Fool CAPS, a "penny stock" is any stock trading under $10, and you'll find some of the best CAPS All-Stars regularly seeking out winning single-digit investments. We identify them with a penny icon and by pairing up their opinions with some top companies trading for pennies on the dollar, relatively speaking, we may end up with more than just chump change.

Of course, just because a stock is low priced, isn't necessarily enough to suggest it will have an easier time recording big gains. Low-priced stocks are often low-priced for a reason. But this week we look at drug developer PDL BioPharma (Nasdaq: PDLI ) , which has seen its shares rise 35% over the past year, yet trades just over $7 a share and is garnering top honors at CAPS.

PDL BioPharma snapshot

Market Cap $993 million

Revenue, TTM $356 million

Return on Investment (5-year) 37.5%

Dividend/Yield $0.60/9.2%

Recent Price $7.07

CAPS Rating (out of 5) ****

Growth is growth

It's easy to see why investors have bid up shares of PDL BioPharma over the past year. With a passel of drugs on the market, the drugmaker is receiving royalties on global sales of drugs from some of the biggest names in the pharmaceutical industry, including Roche, Novartis (NYSE: NVS ) , Elan (NYSE: ELN ) , and Biogen Idec (Nasdaq: BIIB ) .

All of PDL's revenues in the second quarter came from royalties, and they were 3% higher than in the year-ago period. Macular degeneration treatment Lucentis enjoyed a 15% increase in sales for Novartis, multiple sclerosis drug Tysabri was up 13% for Elan and Biogen, and cancer therapy Herceptin saw sales rise 4% for Roche. Its other cancer treatment Avastin was stung after the FDA yanked approval for the breast cancer therapy and sales fell 1% in the quarter.

While it had to start paying back some royalties for international sales of Lucentis due to a settlement with Novartis, PDL inked a new deal with Roche for sales of metastatic breast cancer treatment Perjeta that analysts estimate could be worth as much as $1 billion. According to Roche, adding Perjeta to Herceptin and chemotherapy is the only regimen to have shown a significant improvement in survival rates without the cancer progressing compared to just Herceptin and chemo alone. PDL will begin receiving royalties for Perjeta this quarter.

Penny for your thoughts Considering the growth in its drug portfolio on the market and the potentially much higher sales it can realize from new agreements, I'm surprised PDL BioPharma trades at what seems to be a big discount. The stock goes for just five times earnings and only for times estimates, and when you factor in how much analysts are expecting earnings to grow the pharmaceutical is trading at a fraction of that growth rate. Moreover, its enterprise value goes off at just five times the amount of free cash flow it generates, which is exceptionally cheap.

The risk here is that a certain patent tied to Avastin, Herceptin, Lucentis, Xolair, and Tysabri expired in Europe in 2009 and only through "supplementary protection certificates" issued by various countries has it continued to enjoy exclusivity. Those SPCs expire in 2014 while other patents will expire next year.

Make some change CAPS member SamsaricSufferer believes PDL's pipeline of drug candidates should carry it through, and I believe the market has more than compensated for the risks associated with patent expiry. I've already rated it to outperform the broad market averages on CAPS, finding it a better bet these days than Bristol-Myers Squibb (NYSE: BMY ) , which is finding generic competition much sooner than PDL, and recently had a setback in its important hepatitis C portfolio. But you can tell me in the comments box below whether you think PDL BioPharma is a pharmaceutical penny stock that makes perfect "cents" for your portfolio.

With a dividend yielding 8.5%, PDL also offers investors an attractive payment as compensation for the risk it entails. However, The Motley Fool has found nine solid investment plays that won't cause you to lose sleep. Get your copy of this free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" by clicking the link and downloading it today. Did I mention it's free?

ARRY look for breakout today over 5.39 yearly high

MERU - Meru Networks - Looks good 3.20 to 4.00

Hot Stocks for Monday 8/10 - OMEX & GLDD & MGAM

BOTH OF THESE HAVE GREAT UPSIDE POTIENTIAL -

Hot Stock for Monday - 8/13 - inContact, Inc. (SAAS)

YEARLY HIGH 6.00 look for explosion thru that price

New Star Analyst Rankings for inContact, Inc.StarMine(Fri 10:26AM EDT) inContact beats by $0.02, beats on revsBriefing.com(Thu, Aug 9)

Leading National Bank Selects inContact Cloud-based Dialer SolutionPR Newswire(Thu, Aug 2)

Leading Medical Technology Company Selects inContact to Transform Service ExperiencePR Newswire(Tue, Jul 31)

Industry Veteran Bill Robinson Joins inContact to Lead Global Sales of Market-Leading Cloud Contact Center Software OfferingPR Newswire(Tue, Jul 17)

2 Stock to Watch for Friday 8/10 - SIRI & NOK

ARNA trade today - very nice 7.32 to 7.44

This trade set up perfect - with limited downside due to base a pop was more likely into an earnings play -

YOU CAN SEE MY BUY AND SELL TRIANGLES IN MIDDLE OF CHART - THIS IS WHY YOU SELL WHEN IT RUNS ON A RISKY STOCK LIKE ARNA

MXWL - made same move as PDLI will - suck out try before the big run - picked up some cheap shares at 6.96 today

PDLI - new star ranking *****

PDLI - Beats Estimates & Insider buying!!! Target 8.00+

PDL BioPharma Inc. (PDLI) posted second-quarter earnings of 53 cents per share, above the year-ago figure of 39 cents and the Zacks Consensus Estimate of 49 cents. Earnings were boosted by higher revenues. Moreover, a lower share count also aided earnings in the reported quarter. PDL BioPharma generated second-quarter 2012 revenues of $125.9 million, up 3.1%. Revenues were slightly above the guidance of $125 million announced by the company in June 2012. The Zacks Consensus Estimate was also $125 million. Quarter in Detail PDL BioPharma generated the entire revenues for the second quarter of 2012 from royalties. PDL BioPharma receives royalties on worldwide net sales of Roche Holdings Ltd.'s (RHHBY) Avastin and Herceptin; Roche/ Novartis’ (NVS) Lucentis and Xolair; and Elan Corporation/Biogen Idec’s (ELN/ BIIB) Tysabri. The company will also receive royalties on Roche’s Perjeta (pertuzumab), which was launched in the US in June 2012. Royalty revenues of $125.9 million represented an increase of 3.1% from the year-ago period. Increased royalties on sales of Herceptin, Lucentis, Xolair and Tysabri drove second quarter 2012 royalties. Effective from the second quarter of 2011, PDL BioPharma started paying back a portion of the royalties it receives on Lucentis sales outside the US to Novartis. The payment is made in accordance with a settlement agreement, which the companies had entered into in February 2011. The second-quarter 2012 revenue is net of this payment. General and administrative (G&A) expenses were $5.1 million in the reported quarter, up approximately 36.3% due to the company’s efforts to obtain new royalty assets, legal expenses and compensation related expenses. On June 14, 2012, PDL BioPharma paid the second quarterly dividend of 15 cents per share. The company is expected to provide third-quarter 2012 revenue guidance in September 2012.

PDLI - buying 7.05 target 8.05

PDLI - huge breakout coming - filled 7.05

PCLN, CMG, GOOG - called drop back in January

I was going through some old emails that I remembered looking at some charts and thinking - WOW - these things are way overextended and up HUGE - they have to reverse and fill in some major gaps - GOOG was so toppy - it got crushed on earnings - 60 points - firgued these all were next - took more time then expected but take a look at the charts and dates on them

ARNA - Trade #11 - .04 profit

Buy ARNA 7.40 12:16:05 PM

Buy ARNA 7.40 12:16:05 PM

Buy ARNA 7.40 12:16:05 PM

Buy ARNA 7.40 12:16:05 PM

Buy ARNA 7.38 12:16:48 PM

Sell ARNA 7.45 12:28:27 PM

Sell ARNA 7.44 12:34:29 PM

Sell ARNA 7.44 12:34:39 PM

Sell ARNA 7.44 12:34:43 PM

Sell ARNA 7.44 12:34:43 PM

ENTR - Trade #10 - loss .01

Buy ENTR 5.88 11:37:46 AM

Buy ENTR 5.88 11:37:46 AM

Buy ENTR 5.88 11:37:46 AM

Buy ENTR 5.88 11:37:46 AM

Buy ENTR 5.88 11:37:46 AM

Buy ENTR 5.89 11:37:50 AM

Buy ENTR 5.89 11:37:51 AM

Buy ENTR 5.89 11:37:51 AM

Buy ENTR 5.89 11:37:51 AM

Buy ENTR 5.89 11:37:51 AM

Buy ENTR 5.89 11:38:02 AM

Buy ENTR 5.89 11:38:02 AM

Buy ENTR 5.89 11:38:02 AM

Buy ENTR 5.89 11:38:02 AM

Buy ENTR 5.89 11:38:02 AM

Buy ENTR 5.89 11:38:02 AM

Buy ENTR 5.89 11:38:02 AM

Buy ENTR 5.89 11:38:02 AM

Sell ENTR 5.87 12:06:04 PM

Sell ENTR 5.87 12:06:04 PM

Sell ENTR 5.87 12:06:04 PM

Sell ENTR 5.87 12:06:04 PM

Sell ENTR 5.87 12:06:04 PM

Sell ENTR 5.87 12:06:04 PM

Sell ENTR 5.88 12:08:21 PM

Sell ENTR 5.88 12:08:21 PM

Sell ENTR 5.88 12:08:21 PM

Sell ENTR 5.88 12:08:21 PM

Sell ENTR 5.87 12:06:04 PM

BPAX - Trade #9 - .09 profit

Buy BPAX 1.40 @ 2:06:20 PM

Buy BPAX 1.43 @ 2:06:44 PM

Buy BPAX 1.43 @ 2:06:44 PM

Buy BPAX 1.42 @ 2:07:55 PM

Buy BPAX 1.42 @ 2:07:55 PM

Buy BPAX 1.42 @ 2:07:55 PM

Buy BPAX 1.42 @ 2:07:55 PM

Buy BPAX 1.40 @ 2:11:06 PM

Buy BPAX 1.40 @ 2:11:06 PM

Buy BPAX 1.40 @ 2:11:06 PM

Buy BPAX 1.40 @ 2:11:06 PM

Buy BPAX 1.40 @ 2:11:06 PM 1.41

Sell BPAX 1.48 @ 2:47:15 PM

Sell BPAX 1.48 @ 2:47:15 PM

Sell BPAX 1.48 @ 2:47:15 PM

Sell BPAX 1.48 @ 2:47:15 PM

Sell BPAX 1.48 @ 2:47:23 PM

Sell BPAX 1.48 @ 2:47:23 PM

Sell BPAX 1.48 @ 2:47:23 PM

Sell BPAX 1.59 @ 3:02:08 PM

Sell BPAX 1.59 @ 3:02:08 PM 1.50 @

WRES - Trade #8 - .04 profit

Buy WRES 2.54 @ 10:35:43 AM

Buy WRES 2.54 @ 10:35:43 AM

Buy WRES 2.54 @ 10:35:43 AM

Buy WRES 2.54 @ 10:35:43 AM

Buy WRES 2.54 @ 10:35:43 AM

Buy WRES 2.55 @ 10:36:14 AM

Buy WRES 2.55 @ 10:36:14 AM

Buy WRES 2.55 @ 10:36:14 AM

Buy WRES 2.54 @ 10:36:51 AM

Buy WRES 2.55 @ 10:39:38 AM

Buy WRES 2.55 @ 10:39:38 AM

Buy WRES 2.55 @ 10:39:39 AM

Buy WRES 2.55 @ 10:39:39 AM

Buy WRES 2.55 @ 10:39:39 AM

Buy WRES 2.55 @ 10:39:39 AM

Buy WRES 2.56 @ 10:52:09 AM @

Sell WRES 2.57 @ 11:25:30 AM

Sell WRES 2.57 @ 11:25:30 AM

Sell WRES 2.57 @ 11:25:30 AM

Sell WRES 2.57 @ 11:25:30 AM

Sell WRES 2.57 @ 11:25:30 AM @

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.58 @ 12:05:16 PM

Sell WRES 2.57 @ 12:08:00 PM

Sell WRES 2.57 @ 12:08:00 PM

Sell WRES 2.57 @ 12:08:00 PM

Sell WRES 2.57 @ 12:08:00 PM

KCG - Trade #7 - .04 profit - another quickie less than 5 minutes

Buy KCG 3.08 10:38:32 AM

Buy KCG 3.08 10:38:32 AM

Buy KCG 3.08 10:38:32 AM

Buy KCG 3.08 10:38:32 AM

Buy KCG 3.08 10:38:32 AM

Sell KCG 3.14 10:43:49 AM

Sell KCG 3.10 10:53:11 AM

KCG - Trade #6 - quick one .035 profit

Buy KCG 3.00 10:15:02 AM

Buy KCG 3.00 10:15:02 AM

Buy KCG 3.00 10:15:02 AM

Buy KCG 3.00 10:15:02 AM

Buy KCG 3.00 10:15:02 AM

Sell KCG 3.04 10:24:54 AM

Sell KCG 3.03 10:32:25 AM

KCG - Trade #5 - .15 cent profit

The stock ran right to 3.50 after sold at 3.14 - then reversed and came back to 2.80 - Did great on this trade - Tip - Sell on the way up in pieces selling 1/3 first and scaling out of rest at higher prices raising the bar and playing with the houses money!!

Buy KCG 2.87 9:38:01 AM

Buy KCG 2.87 9:38:01 AM

Buy KCG 2.88 9:38:12 AM

Buy KCG 2.88 9:38:12 AM

Buy KCG 2.88 9:38:12 AM

Buy KCG 2.88 9:38:12 AM

Buy KCG 2.88 9:38:12 AM

Buy KCG 2.88 9:38:12 AM AVERAGE 2.88

Sell KCG 2.99 9:38:49 AM

Sell KCG 2.97 9:39:06 AM

Sell KCG 3.14 9:40:06 AM AVERAGE 3.03

NYT - Trade #4 - .05 profit

Stock went higher after but turned quick and went to 7.78 - I don't care as I had my target of 7.89 and it went to 7.87 at 9:52 - waited 5 more minutes and it turned back -good trade - eventually went to 7.95

Buy NYT 7.81 @ 9:36:20 AM

Buy NYT 7.81 @ 9:36:20 AM

Buy NYT 7.81 @ 9:36:20 AM

Buy NYT 7.81 @ 9:36:20 AM

Buy NYT 7.82 @ 9:36:35 AM

Buy NYT 7.82 @ 9:36:35 AM

Buy NYT 7.82 @ 9:36:35 AM

Sell NYT 7.87 @ 9:52:25 AM

Sell NYT 7.86 @ 9:57:23 AM

Sell NYT 7.86 @ 9:57:23 AM

Sell NYT 7.86 @ 9:57:23 AM

WRES Trade #3 - loss .04

They sucked me out I stick to my stop loss - however I noticed the suck out and the trick as they were going reverse it and run it. Market makers do that to take your stock from weak traders - I noticed and bought back to make a nice profit.

Buy WRES 2.55 @ 10:08:29 AM

Buy WRES 2.55 @ 10:08:29 AM

Buy WRES 2.55 @ 10:08:29 AM

Buy WRES 2.55 @ 10:08:29 AM

Buy WRES 2.55 @ 10:08:29 AM

Sell WRES 2.51 @ 10:30:04 AM

Sell WRES 2.51 @ 10:30:04 AM

Sell WRES 2.51 @ 10:30:04 AM

Sell WRES 2.51 @ 10:30:04 AM

Sell WRES 2.51 @ 10:30:04 AM

Sell WRES 2.51 @ 10:30:16 AM